1. 2329 A randomized phase III study of S-1 alone versus S-1 plus immunomodulator lentinan for unresectable or recurrent gastric cancer (JFMC36–0701). (September 2015) Authors: Nishikawa, K.; Yoshino, S.; Morita, S.; Takahashi, T.; Sakata, K.; Nagao, J.; Nemoto, H.; Murakami, N.; Matsuda, T.; Hasegawa, H.; Shimizu, R.; Yoshikawa, T.; Osanai, H.; Imano, M.; Naitoh, H.; Yabe, M.; Tanaka, A.; Sakamoto, J.; Saji, S.; Oka, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗